Cyclacel Pharmaceuticals Inc
General ticker "CYCC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $801.0K
Cyclacel Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -45.0%.
Estimated limits based on current volatility of 4.5%: low 0.32$, high 0.35$
Factors to consider:
- Current price 86.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.37$, 7.19$]
- 2024-12-30 to 2025-12-30 estimated range: [2.13$, 5.88$]
Financial Metrics affecting the CYCC estimates:
- Negative: Non-GAAP EPS, $ of -27.23 <= 0.10
- Negative: Operating profit margin, % of -98.38 <= 1.03
- Negative: Operating cash flow per share per price, % of -82.93 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term CYCC quotes
Long-term CYCC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.42MM |
| Operating Expenses | $22.94MM | $27.66MM | $25.87MM |
| Operating Income | $-22.94MM | $-27.66MM | $-25.45MM |
| Non-Operating Income | $0.20MM | $1.74MM | $-0.10MM |
| R&D Expense | $15.48MM | $20.27MM | $19.16MM |
| Income(Loss) | $-22.73MM | $-25.91MM | $-25.55MM |
| Taxes | $-3.85MM | $-4.72MM | $-3.00MM |
| Profit(Loss) | $-18.89MM | $-21.20MM | $-22.55MM |
| Stockholders Equity | $37.26MM | $15.94MM | $0.61MM |
| Inventory | $0.58MM | $5.64MM | $0.00MM |
| Assets | $42.59MM | $28.05MM | $8.80MM |
| Operating Cash Flow | $-18.54MM | $-20.83MM | $-16.11MM |
| Capital expenditure | $0.03MM | $0.01MM | $0.01MM |
| Investing Cash Flow | $-0.03MM | $-0.01MM | $-0.01MM |
| Financing Cash Flow | $21.74MM | $3.00MM | $0.85MM |
| Earnings Per Share* | $-31.74 | $-32.23 | $-26.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.